Még nem toboroz
AAV9-ASAH1 intracisterna magna Gene Therapy (GNT0009) in Patients with Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA - PME)
2026-527323-10-00· 1/2. fázis· Genethon· Forrás
Toboroz
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
2022-502365-26-00· 3. fázis· Novartis Pharma AG· Forrás
Toboroz
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
2023-505575-69-01· 3. fázis· Institut Gustave Roussy· Forrás
Toboroz
A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
2024-520125-36-00· 1. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás
Még nem toboroz
A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
2024-516570-30-00· 2. fázis· Centre Hospitalier De Versailles· Forrás
Fut, nem toboroz
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
NCT07134088· 1/2. fázis· Amgen· Forrás
Toboroz
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45
NCT07038824· 1/2. fázis· Entrada Therapeutics, Inc.· Forrás
Toboroz
Study to evaluate efficacy and safety of inclisiran in children aged 2 to under 12 years of age with homozygous familial hypercholesterolemia
2024-514595-41-00· 3. fázis· Novartis Pharma AG· Forrás
Toboroz
A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44
NCT07037862· 1/2. fázis· Entrada Therapeutics, Inc.· Forrás
Fut, nem toboroz
Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterolemia.
2024-514594-21-00· 3. fázis· Novartis Pharma AG· Forrás
Toboroz
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
NCT07334301· 1/2. fázis· University of Birmingham· Forrás
Fut, nem toboroz
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
2023-507655-30-00· 3. fázis· Eli Lilly & Co.· Forrás
Meghívásos bevonás
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
NCT06191315· 3. fázis· Sanofi· Forrás
Fut, nem toboroz
A study to investigate the efficacy and safety of tezepelumab compared with placebo in children 5 to < 12 years old with severe asthma
2022-502984-39-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology.
2022-500933-10-00· 4. fázis· Centre Hospitalier Universitaire De Toulouse· Forrás
Toboroz
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
NCT05748171· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855· 3. fázis· Scholar Rock, Inc.· Forrás
Meghívásos bevonás
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
NCT05594992· 3. fázis· JCR Pharmaceuticals Co., Ltd.· Forrás
Fut, nem toboroz
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035· 3. fázis· PedAL BCU, LLC· Forrás
Toboroz
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
NCT05384821· 1/2. fázis· Centre Oscar Lambret· Forrás
Fut, nem toboroz
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
NCT04573023· 3. fázis· JCR Pharmaceuticals Co., Ltd.· Forrás
Toboroz
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
NCT04356326· 3. fázis· Centre Hospitalier Intercommunal Creteil· Forrás
Fut, nem toboroz
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907· 1/2. fázis· University of Birmingham· Forrás
Toboroz
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
2022-501454-11-00· 3. fázis· GPOH gGmbH· Forrás
Toboroz
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Fut, nem toboroz
Phase II trial of nivolumab for pediatric and adult relapsing/refractory ALK+ anaplastic large cell lymphoma, for evaluation of response in patients with progressive disease (Cohort 1) or as consolidative immunotherapy in patients in complete remission after relapse (Cohort 2) - NIVO ALCL
2024-516807-17-00· 2. fázis· Institut Gustave Roussy· Forrás
Fut, nem toboroz
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
NCT03643133· 2. fázis· UNICANCER· Forrás
Fut, nem toboroz
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
NCT03793478· 1/2. fázis· Daiichi Sankyo· Forrás
Toboroz
A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
2023-504880-18-00· 1/2. fázis· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Forrás
Toboroz
Study in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy of GIVINOSTAT in all the patients affected with Duchenne Muscolar Dystrophy who have been already treated in one of the GIVINOSTAT studies in the past
2023-504520-26-00· 3. fázis· Italfarmaco S.p.A.· Forrás
Toboroz
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
NCT02813135· 1/2. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Fut, nem toboroz
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT02724163· 3. fázis· University of Birmingham· Forrás
Fut, nem toboroz
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
NCT00470223· 3. fázis· UNICANCER· Forrás